Woodcock 'Lives In Fear' Outdated Labels Will Lead To Patient Harm

By David Roza / April 5, 2018 at 6:56 PM
Janet Woodcock, director of FDA's Center for Drug Evaluation and Research (CDER), said she "live[s] in fear" of providers using outdated treatment methods based on FDA-approved drug labels which, the director admitted, are updated less and less after FDA first approves a drug. Woodcock made clear that FDA cannot play an omnipresent role in making sure labels are up to date, but Friends of Cancer Research, in a new paper, says the agency should collaborate with developers of compendia and...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.